mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.08 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.09 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |